Cargando…
Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer
BACKGROUND AND PURPOSE: Leptomeningeal metastases (LM) is the end-event of lung cancer and the prognosis is dismal. Few studies explored the prognostic performance of systematic immunological levels in lung cancer patients with LM. Our study aimed to explore the possible relationship between the pro...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934871/ https://www.ncbi.nlm.nih.gov/pubmed/35321403 http://dx.doi.org/10.2147/CMAR.S347323 |
_version_ | 1784671924840824832 |
---|---|
author | Hong, Ye Duan, Ping He, Lang Li, Qing Chen, Yueyun Wang, Peipei Fu, Yang Liu, Ting Ding, Zhenyu |
author_facet | Hong, Ye Duan, Ping He, Lang Li, Qing Chen, Yueyun Wang, Peipei Fu, Yang Liu, Ting Ding, Zhenyu |
author_sort | Hong, Ye |
collection | PubMed |
description | BACKGROUND AND PURPOSE: Leptomeningeal metastases (LM) is the end-event of lung cancer and the prognosis is dismal. Few studies explored the prognostic performance of systematic immunological levels in lung cancer patients with LM. Our study aimed to explore the possible relationship between the prognosis of LM and systematic immunological level and other clinical characteristics. METHODS: This retrospective, multi-institutional, observational study was conducted in 4 tertiary centers in China. Patients were screened from January 2009 to May 2019. Patients with radiographically or histologically confirmed LM were enrolled. The data of systematic immunological level and other clinical characteristics of each patient were extracted and statistically analyzed to establish a prognostic model based on statistical analysis results. The predictive accuracy and discriminative capability of the model were evaluated by the calibration curve and concordance index (C-index). RESULTS: A total of 109 patients were enrolled in the study. Patients with adenocarcinoma, tumors harboring EGFR mutation, at their age of 50–59, with either bone, brain, or lung metastases, were enriched in this cohort. The median overall survival (OS) was 20.4 months (95% CI: 15.2–25.6). Cox univariate and multivariate analysis revealed better PS (0–1), no distant lymph nodes metastasis (DLNM), simultaneous diagnosis of lung cancer and leptomeningeal metastasis (SDLL), and lower neutrophil to lymphocyte ratio (NLR), were associated with better OS. Based on these independent prognostic variables, a prognostic nomogram model with a C-index for OS prediction of 0.71, was constructed. The actual probability of survival at 1-, 2- and 3-year showed good concordance with the prediction curve of our nomogram. CONCLUSION: The systematic immunological level was an independent prognostic factor of lung cancer patients with LM. The prognostic model based on statistical analysis had a good ability to predict the OS of patients. |
format | Online Article Text |
id | pubmed-8934871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-89348712022-03-22 Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer Hong, Ye Duan, Ping He, Lang Li, Qing Chen, Yueyun Wang, Peipei Fu, Yang Liu, Ting Ding, Zhenyu Cancer Manag Res Original Research BACKGROUND AND PURPOSE: Leptomeningeal metastases (LM) is the end-event of lung cancer and the prognosis is dismal. Few studies explored the prognostic performance of systematic immunological levels in lung cancer patients with LM. Our study aimed to explore the possible relationship between the prognosis of LM and systematic immunological level and other clinical characteristics. METHODS: This retrospective, multi-institutional, observational study was conducted in 4 tertiary centers in China. Patients were screened from January 2009 to May 2019. Patients with radiographically or histologically confirmed LM were enrolled. The data of systematic immunological level and other clinical characteristics of each patient were extracted and statistically analyzed to establish a prognostic model based on statistical analysis results. The predictive accuracy and discriminative capability of the model were evaluated by the calibration curve and concordance index (C-index). RESULTS: A total of 109 patients were enrolled in the study. Patients with adenocarcinoma, tumors harboring EGFR mutation, at their age of 50–59, with either bone, brain, or lung metastases, were enriched in this cohort. The median overall survival (OS) was 20.4 months (95% CI: 15.2–25.6). Cox univariate and multivariate analysis revealed better PS (0–1), no distant lymph nodes metastasis (DLNM), simultaneous diagnosis of lung cancer and leptomeningeal metastasis (SDLL), and lower neutrophil to lymphocyte ratio (NLR), were associated with better OS. Based on these independent prognostic variables, a prognostic nomogram model with a C-index for OS prediction of 0.71, was constructed. The actual probability of survival at 1-, 2- and 3-year showed good concordance with the prediction curve of our nomogram. CONCLUSION: The systematic immunological level was an independent prognostic factor of lung cancer patients with LM. The prognostic model based on statistical analysis had a good ability to predict the OS of patients. Dove 2022-03-15 /pmc/articles/PMC8934871/ /pubmed/35321403 http://dx.doi.org/10.2147/CMAR.S347323 Text en © 2022 Hong et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Hong, Ye Duan, Ping He, Lang Li, Qing Chen, Yueyun Wang, Peipei Fu, Yang Liu, Ting Ding, Zhenyu Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer |
title | Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer |
title_full | Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer |
title_fullStr | Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer |
title_full_unstemmed | Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer |
title_short | Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer |
title_sort | systematic immunological level determined the prognosis of leptomeningeal metastasis in lung cancer |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934871/ https://www.ncbi.nlm.nih.gov/pubmed/35321403 http://dx.doi.org/10.2147/CMAR.S347323 |
work_keys_str_mv | AT hongye systematicimmunologicalleveldeterminedtheprognosisofleptomeningealmetastasisinlungcancer AT duanping systematicimmunologicalleveldeterminedtheprognosisofleptomeningealmetastasisinlungcancer AT helang systematicimmunologicalleveldeterminedtheprognosisofleptomeningealmetastasisinlungcancer AT liqing systematicimmunologicalleveldeterminedtheprognosisofleptomeningealmetastasisinlungcancer AT chenyueyun systematicimmunologicalleveldeterminedtheprognosisofleptomeningealmetastasisinlungcancer AT wangpeipei systematicimmunologicalleveldeterminedtheprognosisofleptomeningealmetastasisinlungcancer AT fuyang systematicimmunologicalleveldeterminedtheprognosisofleptomeningealmetastasisinlungcancer AT liuting systematicimmunologicalleveldeterminedtheprognosisofleptomeningealmetastasisinlungcancer AT dingzhenyu systematicimmunologicalleveldeterminedtheprognosisofleptomeningealmetastasisinlungcancer |